207 related articles for article (PubMed ID: 8219249)
1. Mechanisms of hormone resistance in breast cancer.
Horwitz KB
Breast Cancer Res Treat; 1993; 26(2):119-30. PubMed ID: 8219249
[TBL] [Abstract][Full Text] [Related]
2. Hormone-resistant breast cancer or "feeding the hand that bites you".
Horwitz KB
Prog Clin Biol Res; 1994; 387():29-45. PubMed ID: 7972253
[TBL] [Abstract][Full Text] [Related]
3. How do breast cancers become hormone resistant?
Horwitz KB
J Steroid Biochem Mol Biol; 1994 Jun; 49(4-6):295-302. PubMed ID: 8043492
[TBL] [Abstract][Full Text] [Related]
4. T47DCO cells, genetically unstable and containing estrogen receptor mutations, are a model for the progression of breast cancers to hormone resistance.
Graham ML; Krett NL; Miller LA; Leslie KK; Gordon DF; Wood WM; Wei LL; Horwitz KB
Cancer Res; 1990 Oct; 50(19):6208-17. PubMed ID: 2400987
[TBL] [Abstract][Full Text] [Related]
5. Can hormone "resistant" breast cancer cells be inappropriately stimulated by tamoxifen?
Horwitz KB
Ann N Y Acad Sci; 1993 Jun; 684():63-74. PubMed ID: 8317847
[TBL] [Abstract][Full Text] [Related]
6. Genomic agonism and phenotypic antagonism between estrogen and progesterone receptors in breast cancer.
Singhal H; Greene ME; Tarulli G; Zarnke AL; Bourgo RJ; Laine M; Chang YF; Ma S; Dembo AG; Raj GV; Hickey TE; Tilley WD; Greene GL
Sci Adv; 2016 Jun; 2(6):e1501924. PubMed ID: 27386569
[TBL] [Abstract][Full Text] [Related]
7. Expression of estrogen receptor (ER) (beta)cx protein in ER(alpha)-positive breast cancer: specific correlation with progesterone receptor.
Saji S; Omoto Y; Shimizu C; Warner M; Hayashi Y; Horiguchi S; Watanabe T; Hayashi S; Gustafsson JA; Toi M
Cancer Res; 2002 Sep; 62(17):4849-53. PubMed ID: 12208729
[TBL] [Abstract][Full Text] [Related]
8. Estrogen and progesterone receptors in the endometrium of postmenopausal breast cancer patients treated with tamoxifen and progestogens.
Cohen I; Altaras MM; Beyth Y; Shapira J; Figer A; Tepper R; Cordoba M; Yigal D; Bernheim J
Gynecol Oncol; 1997 Apr; 65(1):83-8. PubMed ID: 9103396
[TBL] [Abstract][Full Text] [Related]
9. Estrogenic potential of progestins in oral contraceptives to stimulate human breast cancer cell proliferation.
Jeng MH; Parker CJ; Jordan VC
Cancer Res; 1992 Dec; 52(23):6539-46. PubMed ID: 1423300
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms involved in the evolution of progestin resistance in human breast cancer cells.
Murphy LC; Dotzlaw H; Wong MS; Miller T; Murphy LJ
Cancer Res; 1991 Apr; 51(8):2051-7. PubMed ID: 1849041
[TBL] [Abstract][Full Text] [Related]
11. Cellular heterogeneity and mutant oestrogen receptors in hormone resistant breast cancer.
Horwitz KB
Cancer Surv; 1992; 14():41-54. PubMed ID: 1423329
[TBL] [Abstract][Full Text] [Related]
12. Measurement of steroid hormone receptors in breast cancer patients on tamoxifen.
Encarnación CA; Ciocca DR; McGuire WL; Clark GM; Fuqua SA; Osborne CK
Breast Cancer Res Treat; 1993; 26(3):237-46. PubMed ID: 8251648
[TBL] [Abstract][Full Text] [Related]
13. Estrogen receptor-positive, progesterone receptor-negative breast cancer: association with growth factor receptor expression and tamoxifen resistance.
Arpino G; Weiss H; Lee AV; Schiff R; De Placido S; Osborne CK; Elledge RM
J Natl Cancer Inst; 2005 Sep; 97(17):1254-61. PubMed ID: 16145046
[TBL] [Abstract][Full Text] [Related]
14. A metastatic breast tumor cell line, GI-101A, is estrogen receptor positive and responsive to estrogen but resistant to tamoxifen.
Morrissey JJ; Raney S
Cell Biol Int; 1998; 22(6):413-9. PubMed ID: 10328849
[TBL] [Abstract][Full Text] [Related]
15. Long-term hydroxytamoxifen treatment of an MCF-7-derived breast cancer cell line irreversibly inhibits the expression of estrogenic genes through chromatin remodeling.
Badia E; Duchesne MJ; Semlali A; Fuentes M; Giamarchi C; Richard-Foy H; Nicolas JC; Pons M
Cancer Res; 2000 Aug; 60(15):4130-8. PubMed ID: 10945620
[TBL] [Abstract][Full Text] [Related]
16. Breast cancer proteomics by laser capture microdissection, sample pooling, 54-cm IPG IEF, and differential iodine radioisotope detection.
Neubauer H; Clare SE; Kurek R; Fehm T; Wallwiener D; Sotlar K; Nordheim A; Wozny W; Schwall GP; Poznanović S; Sastri C; Hunzinger C; Stegmann W; Schrattenholz A; Cahill MA
Electrophoresis; 2006 May; 27(9):1840-52. PubMed ID: 16645950
[TBL] [Abstract][Full Text] [Related]
17. Altered expression of estrogen-regulated genes in a tamoxifen-resistant and ICI 164,384 and ICI 182,780 sensitive human breast cancer cell line, MCF-7/TAMR-1.
Lykkesfeldt AE; Madsen MW; Briand P
Cancer Res; 1994 Mar; 54(6):1587-95. PubMed ID: 8137264
[TBL] [Abstract][Full Text] [Related]
18. Synthetic progestins induce proliferation of breast tumor cell lines via the progesterone or estrogen receptor.
Kalkhoven E; Kwakkenbos-Isbrücker L; de Laat SW; van der Saag PT; van der Burg B
Mol Cell Endocrinol; 1994 Jun; 102(1-2):45-52. PubMed ID: 7926273
[TBL] [Abstract][Full Text] [Related]
19. [Tamoxifen-induced progesterone receptors in breast tumors].
Tsyrlina EV; Semiglazov VF; Nurgaziev KSh; Ivanova OA
Vopr Onkol; 1991; 37(9-10):916-21. PubMed ID: 1842650
[TBL] [Abstract][Full Text] [Related]
20. The value of estrogen and progesterone receptor determinations in advanced breast cancer. Estrogen receptor level but not progesterone receptor level correlates with response to tamoxifen.
Bezwoda WR; Esser JD; Dansey R; Kessel I; Lange M
Cancer; 1991 Aug; 68(4):867-72. PubMed ID: 1855186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]